137 related articles for article (PubMed ID: 15476054)
21. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
22. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
[TBL] [Abstract][Full Text] [Related]
23.
El-Newary SA; Abd Elkarim AS; Abdelwahed NAM; Omer EA; Elgamal AM; ELsayed WM
Molecules; 2023 May; 28(11):. PubMed ID: 37298777
[No Abstract] [Full Text] [Related]
24. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model.
Takakura N; Wakabayashi H; Ishibashi H; Yamauchi K; Teraguchi S; Tamura Y; Yamaguchi H; Abe S
J Med Microbiol; 2004 Jun; 53(Pt 6):495-500. PubMed ID: 15150327
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
[TBL] [Abstract][Full Text] [Related]
26. Carvacrol and eugenol effectively inhibit Rhizopus stolonifer and control postharvest soft rot decay in peaches.
Zhou D; Wang Z; Li M; Xing M; Xian T; Tu K
J Appl Microbiol; 2018 Jan; 124(1):166-178. PubMed ID: 29044849
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans.
Nagao JI; Cho T; Mitarai M; Iohara K; Hayama K; Abe S; Tanaka Y
FEMS Yeast Res; 2017 Feb; 17(1):. PubMed ID: 27915244
[TBL] [Abstract][Full Text] [Related]
28. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans.
Braga PC; Sasso MD; Culici M; Alfieri M
Fitoterapia; 2007 Sep; 78(6):396-400. PubMed ID: 17590533
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.
Kobayashi-Sakamoto M; Tamai R; Isogai E; Kiyoura Y
Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742
[TBL] [Abstract][Full Text] [Related]
30. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
31. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Oral Candidiasis Using Photodithazine®- Mediated Photodynamic Therapy In Vivo.
Carmello JC; Alves F; G Basso F; de Souza Costa CA; Bagnato VS; Mima EG; Pavarina AC
PLoS One; 2016; 11(6):e0156947. PubMed ID: 27253525
[TBL] [Abstract][Full Text] [Related]
33. Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis.
Martins RS; Péreira ES; Lima SM; Senna MI; Mesquita RA; Santos VR
J Oral Sci; 2002 Mar; 44(1):41-8. PubMed ID: 12058869
[TBL] [Abstract][Full Text] [Related]
34. In vivo antifungal activity and biocompatibility of Cryptocarya moschata.
de Oliveira Zoccolotti J; Cavalheiro AJ; Tasso CO; de Oliveira CC; Ribas BR; Ferrisse TM; de Souza Costa CA; Jorge JH
Arch Microbiol; 2022 Aug; 204(9):569. PubMed ID: 35987948
[TBL] [Abstract][Full Text] [Related]
35. Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.
Tartor YH; Hassan FAM
J Appl Microbiol; 2017 Nov; 123(5):1088-1099. PubMed ID: 28795522
[TBL] [Abstract][Full Text] [Related]
36. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Anil S; Ellepola AN; Samaranayake LP
J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
[TBL] [Abstract][Full Text] [Related]
37. Antifungal Activity of Eugenol Loaded Electrospun PAN Nanofiber Mats Against Candida Albicans.
Semnani K; Shams-Ghahfarokhi M; Afrashi M; Fakhrali A; Semnani D
Curr Drug Deliv; 2018; 15(6):860-866. PubMed ID: 29484994
[TBL] [Abstract][Full Text] [Related]
38. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
39. Oral Candida: clearance, colonization, or candidiasis?
Cannon RD; Holmes AR; Mason AB; Monk BC
J Dent Res; 1995 May; 74(5):1152-61. PubMed ID: 7790592
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
Vardar-Unlu G; Yağmuroğlu A; Unlu M
Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
